retatrutide phase 2 study results Perceived benefits of treatment for obesity with retatrutide: A qualitative of patients in a clinical trial This week's most cited articles:

21 Remarkably, even in HF-free patients with morbid obesity, cardiac abnormalities can be seen that are consistent with left ventricular (LV) remodelling and dysfunction, including greater LV mass, LV diastolic dysfunction and elevated LV filling pressure

Are there any other serious side effects or risks I should know about

While data from a RCT controls for many of the potential confounding factors, using data from non-primary endpoints requires caveats

As awareness regarding the health impacts of obesity and diabetes increases and funding continues to flow, the market for GLP-1 receptor agonists is poised for substantial growth in the coming years

Legitimate providers comply with your states specific requirements and offer appropriate consultation formats

If you are following a standard retatrutide dose schedule that starts at a low dose, you may experience mild digestive changes within the first few days